There are studies on stem cell therapy for IgA nephropathy, but the technology is still immature, and the disease is still mainly treated with general, drug and renal replacement therapy, and the specific treatment should be in accordance with the doctor’s prescription.
Stem cells are a kind of cells with self-renewal ability, and the related technology has a broad application prospect in the field of tissue and organ replacement therapy. At present, there are medical researches on the use of stem cell transplantation in the treatment of IgA nephropathy, but this technology is still immature, the efficacy is difficult to guarantee, and it is not routinely carried out in clinical treatment, therefore, it is not considered as the main treatment for this disease.
Currently, the treatment of IgA nephropathy mainly includes general treatment, such as avoiding exertion and preventing infection; drug treatment, commonly used antibiotics (such as penicillin), antihypertensive drugs (such as Benadryl), immunosuppressants (such as cyclophosphamide), etc.; and renal substitution therapy, such as peritoneal dialysis, hemodialysis, and renal transplantation surgery.
To sum up, those who are diagnosed with IgA Nephropathy must undergo standardized treatment under doctor’s guidance, and should not blindly dispose of it on their own to avoid improper intervention and adverse consequences. The above medications should be used according to the doctor’s instructions, and should not be used without authorization, so as not to aggravate the condition.